Enzyme News and Research

RSS

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

PhotoMedex, the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA® SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in dermatology offices nationwide and on NEOVA.com.

4 Oct 2013

Harvard University receives $3.5M grant to develop super-resolution microscopy technique

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded a special $3.5 million grant from the National Institutes of Health (NIH) to develop an inexpensive and easy-to-use new microscopy method to simultaneously spot many tiny components of cells.

4 Oct 2013

Genetic condition that attacks multiple organs can be detected using new MRI technique

A genetic condition that attacks multiple organs and usually results in fatal heart problems can be detected using a new MRI technique that was developed at the University of Alberta. The discovery of this new diagnostic tool has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.

3 Oct 2013

Scientists identify new drug for inherited form of cancer with no known cure

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new drug candidate for an inherited form of cancer with no known cure.

3 Oct 2013

Researchers develop new type of E. coli that kills bacteria responsible for hard-to-treat infections

The notorious bacteria E. coli is best known for making people sick, but scientists have reprogrammed the microbe - which also comes in harmless varieties - to make it seek out and fight other disease-causing pathogens.

3 Oct 2013

Researchers to develop nerve agent antidotes that can be used during chemical warfare

Ever since World War II, nerve agents have been a concern in modern warfare and up until now, the only antidotes available acted after the agents damaged the nervous system.

3 Oct 2013

Diet high in certain type of fat may actually increase metabolism

A diet high in a certain type of fat may actually increase metabolism, according to recent research by Texas Tech University nutrition scientists.

3 Oct 2013

NCI explores how erectile dysfunction drugs work to prevent colon cancer

Erectile dysfunction drugs may be able to help prevent or even treat colon cancer, researchers say.

3 Oct 2013

MO BIO Laboratories introduces UltraClean-htp 96 Well Swab DNA Kit

MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the UltraClean-htp 96 Well Swab DNA Kit. The kit is designed for rapid mechanical lysis of microbial cells from low biomass and low inhibitor containing swabs, paper or filter paper for direct application to PCR for metagenomic analysis.

2 Oct 2013

Genetic discovery could take guesswork out of prescribing correct dose of drugs

The discovery of genetic differences affecting up to a third of the population could take the guesswork out of prescribing the correct dose of 25 percent of drugs currently on the market, researchers say.

2 Oct 2013

libragen contributes to success of PolyModE

libragen, a contract research organization dedicated to biocatalysis and metagenomics, has been a major contributor to the success of PolyModE (Polysaccharide Modifying Enzymes), a large collaborative research project funded by the European Community. The project, which began in 2009 and ended in April this year, looked at developing novel polysaccharide modifying enzymes for the optimized use of hydrocolloids as, for example, food additives or novel therapeutic agents in the food sciences and medical industries. Researchers focused on six industry-targeted hydrocolloids (alginates, carrageenans, chitosans, glycosaminoglycans, pectins, and xanthan gums) where traditional chemistry fails to achieve a certain desired modification.

2 Oct 2013

Supply agreement for Clinical Chemistry reagents for the Pictus analyzer range announced by Diatron and Medicon

Diatron MI Plc and Medicon Hellas SA have recently signed an exclusive supply agreement for an extensive range of high quality clinical chemistry reagents for use on the Diatron Pictus range of Clinical chemistry analyzers in all international markets but excludes the USA.

From Diatron 2 Oct 2013

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) heard today.

1 Oct 2013

Researchers discover how aspirin improves survival in patients with colon cancer

Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress heard today (Monday).

30 Sep 2013

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

Omeros Corporation announced that OMS824, its phosphodiesterase 10 inhibitor, has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Huntington's disease.

30 Sep 2013

Researchers discover severe health consequences of folic acid deficiency

Researchers from the universities of Calgary and Cambridge, UK, have discovered that a mutation in a gene necessary for the metabolism of folic acid not only impacts immediate offspring but can also have detrimental health effects, such as spina bifida and heart abnormalities, on subsequent generations.

29 Sep 2013

Enzyme News and Research

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

Harvard University receives $3.5M grant to develop super-resolution microscopy technique

Genetic condition that attacks multiple organs can be detected using new MRI technique

Scientists identify new drug for inherited form of cancer with no known cure

Researchers develop new type of E. coli that kills bacteria responsible for hard-to-treat infections

Researchers to develop nerve agent antidotes that can be used during chemical warfare

Diet high in certain type of fat may actually increase metabolism

NCI explores how erectile dysfunction drugs work to prevent colon cancer

MO BIO Laboratories introduces UltraClean-htp 96 Well Swab DNA Kit

Genetic discovery could take guesswork out of prescribing correct dose of drugs

libragen contributes to success of PolyModE

Supply agreement for Clinical Chemistry reagents for the Pictus analyzer range announced by Diatron and Medicon

Researchers discover how aspirin improves survival in patients diagnosed with colon cancer

Researchers discover how aspirin improves survival in patients with colon cancer

Omeros' OMS824 gets FDA orphan drug designation for treatment of Huntington's disease

Researchers discover severe health consequences of folic acid deficiency

Sister stem cells display considerable differences despite having identical DNA

'Jekyll-and-Hyde' protein could be potent target for developing new cancer drugs

Researchers to use state-of-the-art brain imaging to study mucopolysaccharidosis

Anti-inflammatory drug ibuprofen may fight against certain cancers

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo